CSL Vifor: VFMCRP announces U.S. Court upholds validity of Velphoro patent
U.S. District Court for the District of Delaware rules Teva Pharmaceuticals infringes VFMCRP patent Disputes with all other Abbreviated New Drug Application (ANDA) filers regarding Velphoro have
Source: finanznachrichten.de